Is Type 1 the mildest form of Von Willebrand's Disease?
Yes, it generally involves a partial protein reduction and produces the mildest bleeding tendency compared to Types 2 and 3.
Quick answer
Is Type 1 the mildest form of Von Willebrand's Disease?
Yes, it generally involves a partial protein reduction and produces the mildest bleeding tendency compared to Types 2 and 3.
Not all Von Willebrand's diagnoses carry equal weight, and knowing which specific type is involved changes the whole conversation about risk and breeding.

Breeders planning litters who want precise genetic information before pairing dogs, and owners whose Shar-Pei has already tested positive for a general Von Willebrand's screening and want to understand what type is actually involved.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
Von Willebrand's Disease Type 1 is generally the mildest of three recognized forms of this inherited clotting disorder, involving a partial reduction in clotting protein quantity. A direct DNA test can identify this specific mutation with more precision than a general clotting screen, giving breeders clear, actionable information to avoid carrier-to-carrier pairings.
Type 1 is generally described as the most common and mildest of the three recognized Von Willebrand's types across dog breeds broadly, and precise carrier rates within this specific breed depend on individual bloodlines, making DNA testing a worthwhile precaution before breeding.
The Chinese Shar-Pei's narrow genetic founder population following its near-extinction decades ago means specific inherited mutations, including this Type 1 variant where present in certain lines, can be somewhat more concentrated than in breeds with broader genetic diversity.
This is a purely genetic condition with no environmental trigger; a dog's type and severity are determined entirely at conception based on the genetic status inherited from both parent dogs.
Discuss DNA testing for this specific mutation with your vet if you're planning to breed your Shar-Pei, have a family history of bleeding issues, or received an ambiguous result on a general clotting screen that a more precise genetic test could clarify.
Start here: Chinese Shar-Pei Most Common Genetic Disorders: Screening
See all Chinese Shar PEI health problems, which breeds are prone to von willebrands disease vwd1, or the full Chinese Shar PEI breed guide for temperament, exercise needs and ownership costs.
Genetic testing results are typically available within a few weeks of submitting a sample, giving breeders clear information well ahead of any planned litter, more precise than waiting for a general clotting screen or a bleeding episode to raise concern.
Success looks like a breeding program that avoids producing Type 1-affected puppies entirely, achieved through consistent pre-breeding DNA testing and avoiding carrier-to-carrier pairings, giving every puppy buyer clear, documented genetic information.
Type 1 Von Willebrand's Disease involves a partial reduction in the clotting protein's quantity, generally producing the mildest bleeding tendency of the three recognized types, often manageable with minimal special precautions beyond awareness ahead of a surgical procedure. Type 2 involves a protein that's present in adequate quantity but structurally abnormal and less functional, generally causing more significant bleeding risk than Type 1 despite sometimes looking similar on a basic screening test. Type 3, the rarest and most severe, involves an almost complete absence of the clotting protein and carries substantially higher bleeding risk, including a real potential for spontaneous bleeding events beyond just surgical situations. Lumping all three together under one general label obscures a genuinely important practical distinction, which is exactly why a specific genetic test identifying the type, rather than just a general clotting screen flagging an abnormality, gives owners and breeders a much clearer picture of actual risk.
A direct DNA test for the specific genetic mutation associated with Type 1 can identify a dog as clear, carrier, or affected well before any general clotting screen would even suggest a problem, since the DNA test detects the genetic mutation itself rather than measuring the downstream protein level, which can sometimes appear borderline or ambiguous on a standard blood test. This precision matters enormously for breeding decisions: a carrier dog paired with a genetically clear dog produces no affected puppies, only a mix of clear and carrier offspring, information that a general clotting screen alone couldn't provide with the same confidence. Responsible breeders working with a line known to carry this specific mutation increasingly use this DNA test as a standard pre-breeding step, treating it with the same seriousness as screening for other known inherited conditions rather than relying on a general bleeding-time test that offers a less precise picture.

A breeder in Eugene had a general clotting screen come back borderline for her dog Comet, ahead of a planned litter, an ambiguous result that didn't clearly confirm or rule out a bleeding disorder. Rather than guessing, she requested the specific DNA test for the Type 1 mutation known to occur in some Shar-Pei lines. The test confirmed Comet as a carrier, not affected, with completely normal clotting function of her own. Knowing this precisely, the breeder paired Comet with a DNA-confirmed clear male, resulting in a litter with no risk of an affected puppy, just a possible mix of clear and carrier offspring that she tested and disclosed individually to each puppy buyer.
Key takeaway: The general clotting screen alone left Comet's actual status genuinely unclear, and it was the more precise DNA test that turned an ambiguous result into a confident, well-informed breeding decision.
Type 1 involves a partial reduction in clotting protein quantity and is generally the mildest of the three recognized types, while Type 2 involves a functionally abnormal protein and Type 3 involves an almost complete absence, both typically carrying more significant bleeding risk.
Yes, a direct genetic test for the specific mutation associated with Type 1 can identify a dog as clear, carrier, or affected, offering more precision than a general clotting screen that only measures protein levels indirectly.
It's generally the mildest form, often manageable with awareness and appropriate precautions before surgery or whelping, though any individual dog's actual bleeding risk should still be discussed with a vet rather than assumed based on type alone.
Yes, for lines known to carry this mutation, DNA testing gives breeders precise, actionable information to avoid pairing two carriers, which a general clotting screen alone can't provide with the same confidence.
This risks producing affected puppies in the resulting litter, since both copies of the mutated gene could be inherited. Responsible breeders avoid this specific pairing when carrier status is known.
No, it simply means the surgical team should be aware and can plan accordingly, since Type 1 is generally the mildest form and manageable with appropriate precautions rather than an absolute surgical contraindication.
A DNA test identifies the specific genetic mutation directly, giving a clear clear, carrier, or affected result, while a general clotting screen measures protein function indirectly and can sometimes produce ambiguous or borderline results.
Yes, it generally involves a partial protein reduction and produces the mildest bleeding tendency compared to Types 2 and 3.
Yes, a direct genetic test identifies the specific mutation, giving a clear, carrier, or affected result more precise than a general clotting screen.
No, pairing two carriers risks producing affected puppies; responsible breeders avoid this specific pairing when carrier status is known.
It's a relatively affordable one-time test, a worthwhile investment for any breeding program working with a line known to carry the mutation.
No, it simply requires awareness and appropriate planning, since it's generally the mildest of the three recognized Von Willebrand's types.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





